Securities code: 002821 securities abbreviation: Asymchem Laboratories (Tianjin) Co.Ltd(002821) Announcement No.: 2022-003 Asymchem Laboratories (Tianjin) Co.Ltd(002821) Pharmaceutical Group (Tianjin) Co., Ltd
Announcement on resolutions of the 19th meeting of the 4th board of directors
The company and all members of the board of directors guarantee that the contents of the announcement are true, accurate and complete, and there are no false records, misleading statements or major omissions.
1、 Convening of board meeting
Asymchem Laboratories (Tianjin) Co.Ltd(002821) the notice of the 19th meeting of the Fourth Board of directors of Pharmaceutical Group (Tianjin) Co., Ltd. (hereinafter referred to as “the company”) was sent to all directors, supervisors and senior managers in writing and e-mail on January 7, 2022. The meeting was held by means of communication voting in the conference room on the first floor of the company on January 14, 2022. Nine directors should attend the meeting and nine actually attended. The meeting was presided over by Mr. Hao Hong, chairman of the board. The meeting was held in accordance with relevant laws, administrative regulations, departmental rules, normative documents and the articles of association.
2、 Deliberation on the proposal of the board of directors
The meeting voted by means of communication. After deliberation and voting by all directors attending the meeting, the following resolutions were adopted: the proposal on using idle own funds to purchase financial products was deliberated and adopted
In order to make rational use of idle self owned funds, improve the use efficiency of self owned funds and increase capital income, the company and its subsidiaries intend to use idle self owned funds of no more than RMB 1 million (or equivalent foreign currency) to purchase financial products with good liquidity and high security of financial institutions, and the use period shall not exceed 12 months from the date of deliberation and approval by the board of directors, Within the above service life and limit, the funds can be recycled and used on a rolling basis. The above amount is within the approval authority of the board of directors of the company and does not need to be submitted to the general meeting of shareholders of the company for deliberation.
Voting results: 9 in favor, 0 against and 0 abstention.
For details, please refer to China Securities Journal, securities times and http://www.cn.info.com.cn Announcement information for.
See http://www.cninfo.com.cn for the independent opinions of the independent directors on this proposal（ http://www.cn.info.com.cn./ ）。
3、 Documents for future reference
1. Resolutions of the 19th meeting of the 4th board of directors;
It is hereby announced.
Board of directors of Pharmaceutical Group (Tianjin) Co., Ltd. January 15, 2002
